Treatment of Early-Stage Colorectal Cancer
Key Points
Key Points
- Historically, some of the highest incidence rates for colorectal cancers have been in “more developed” regions. However, approximately 45% of these occur in “less developed” regions, representing 9-10% of cancers in those populations.
- Since different regions of the world, both among and within countries, differ with respect to resource access, ASCO has established a process for stratifying guidelines according to resource availability (basic, limited, enhanced and maximal – See Table 1). This framework emphasizes that variations occur not only between but also within countries—for example, between rural and urban areas.
Treatment
Treatment
...1. Framework of Resource Stratific...
...etastatic, non-obstructing colon cancer Colon C...
...s with non-obstructing, resectable, localize...
Patients with non-obstructing, resectable, l...
...nts with non-obstructing, resectab...
...on Cancer Stages IIB-IIC: T4N0 (Non-obstructing)...
...with non-obstructing, locally advan...
...nts with non-obstructing, locally adv...
...with non-obstructing, locally adva...
...on-obstructing, locally advanced (ie., with...
...s with non-obstructing, locally advance...
Patients with non-obstructing, locally advan...
...ents with non-obstructing, resectable, local...
...Cancer Stages IIB-IIC: T3N0 Obstructing or T...
...s with obstructing, locally advanced...
...atients with obstructing, locally advanced (ie....
...ith obstructing, locally advanced (...
...th obstructing, locally advanced (ie., with invasi...
...ith obstructing, locally advanced (ie., with i...
...tructing Colon Cancer and Colon Cancer Dia...
...s with obstructing, locally advanced (ie., wit...
...igh-risk, obstructing stage II colo...
...high risk, obstructing stage III colo...
...ctal Cancer Stage I– clinical stage T...
...h nonmetastatic cT1N0 rectal cancerBasic and Limi...
...ents with nonmetastatic cT1N0 rectal cancerEnhanc...
Patients with select low risk (cT1N0 witho...
...al Cancer Stage I– clinical...
...s with nonmetastatic cT2N0 rectal cancerBasic and...
...tients with nonmetastatic cT2N0 rectal cancer...
...ith nonmetastatic cT2N0 rectal cancerMaximal...
...l Cancer Stage IIA– clinical stage...
...with clinically resectable cT3N0 rectal canc...
...ith clinically resectable cT3N0 recta...
...with clinically resectable cT3N0 rect...
...ents with clinically resectable cT3N0 rectal ca...
...ients with clinically resectable cT3N0 r...
...ents with clinically resectable cT3N0...
...inically resectable pT3N0 rectal cancer at...
...s with clinically resectable cT3N0 rec...
...nts with clinically resectable cT3N...
Early-Stage Colon Cancer Post-Treatment Surveillan...
...d patients with Stage II CRCBasic...
...s with Stage II CRCLimited Medical...
...eated patients with Stage II CRC at standar...
...eated patients with Stage II CRC at high r...
...ed patients with Stage II CRC at standard and...
...al Cancer Post-Treatment Surveillance...
...ts with rectal cancerBasic Medical hist...
...ated patients with rectal cancer at standard riskL...
...ated patients with rectal cancer at high riskEnh...
...ents with rectal cancer who have n...
...ted patients with rectal cancer at...
...eated patients with rectal cancer at standard ri...
...ated patients with rectal cancer at hi...
...reated patients with rectal cancer,...
Treated patients with rectal cancer at high risk...
...y-Stage Colon Cancer Follow Up (summary...
...Stage Rectal Cancer Follow Up (summary)Havin...